Related Experiment Video

Updated: Aug 6, 2025

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.3K

Exploring the tumor microenvironment in diffuse intrinsic pontine glioma: immunological insights and therapeutic

Bieke Van den Ende1, Matteo Riva1,2, Frederik De Smet3

  • 1Department of Oncology, KU Leuven, Leuven, Belgium.

Journal for Immunotherapy of Cancer
|June 13, 2025
PubMed

Insights

Diffuse intrinsic pontine glioma (DIPG) is a rare pediatric brain tumor. Understanding its immune microenvironment is crucial for developing new immunotherapies to improve patient survival.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Immunology

Background:

  • Diffuse intrinsic pontine glioma (DIPG) is a rare, aggressive pediatric brain tumor originating in the pons.
  • Surgical resection is not feasible, and current treatments like radiation offer limited survival benefits.
  • The tumor's poorly understood immune microenvironment presents a major hurdle for effective immunotherapy development.

Purpose of the Study:

  • To provide a comprehensive review of the current understanding of the DIPG immune landscape.
  • To identify existing research gaps in DIPG immunology.
  • To suggest future research directions for improving DIPG treatment outcomes.

Main Methods:

  • Literature review of recent studies on DIPG immunology.
  • Analysis of tumor immune microenvironment characteristics.
  • Identification of immunological subgroups within DIPG.

Main Results:

  • DIPG tumors are generally considered 'immunologically cold' with minimal immune cell infiltration.
  • Recent research indicates a complex and heterogeneous immune landscape in DIPG.
  • Distinct immunological subgroups within DIPG have been identified.

Conclusions:

  • Further investigation into the DIPG immune microenvironment is essential.
  • Understanding DIPG's immunological heterogeneity may unlock novel therapeutic strategies.
  • Targeting the immune landscape holds promise for improving outcomes in DIPG patients.
Keywords:
Central Nervous System CancerImmunosuppressionImmunotherapy

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.6K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

16.9K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
601